You spent a lot of money on tuition to acquire those finely honed teaching skills. But alas, as youve discovered, teachers arent paid a lot. What you might not have been taught in college, though, is that a side job or two can sweeten your income.
SEE ALSO: 30 Ways to Earn Extra Cash
Here are a few money-making opportunities you can pursue outside of school in summer, at night, on weekends or during holidays. All take advantage of your ability to teach or your rapport with young people or both. And all will leave your wallet fatter for your efforts.
Amusement park staffer. Laugh if youd like, but working as a stage manager at Great Adventure amusement park in Jackson, N.J., years ago was hands down the best summer job Ive ever had. Many kid-focused employees are required to keep the ship moving, and an amusement park summer job is perfect for a teachers work calendar. One state, Virginia, even has a so-called Kings Dominion law on its books that prevents school districts from starting classes before Labor Day to extend the amusement park season.
5 Best Industrial Disributor Stocks To Watch For 2016: E*TRADE Financial Corporation(ETFC)
E*TRADE Financial Corporation, a financial services company, provides brokerage and related products and services primarily to individual retail investors under the E*TRADE Financial brand name. It operates through two segments, Trading and Investing, and Balance Sheet Management. The Trading and Investing segment offers retail brokerage products and services, investor-focused banking products, and corporate services. The Balance Sheet Management segment manages asset allocation; loans previously originated by the company or purchased from third parties; deposits and customer payables; and credit, liquidity, and interest rate risk. The company provides its services to customers through digital platforms; and a network of customer service representatives and financial consultants through phone, email, and online at two branches, as well as in person through 30 branches across the United States. E*TRADE Financial Corporation was incorporated in 1982 and is headquartered in New York, New York.
- [By Jon C. Ogg]
E*TRADE Financial Corp. (NASDAQ: ETFC) was reiterated as Buy, but the price target was raised to $19.50 from $16.50, at Sterne Agee, making the third or fourth such price target upgrade in as many days, but what stands out here is that this appears to now be a “street-high” price target.
5 Best Industrial Disributor Stocks To Watch For 2016: NiSource, Inc(NI)
NiSource Inc., an energy holding company, provides natural gas, electricity, and other products and services in the United States. It operates through two segments, Gas Distribution Operations and Electric Operations. The company provides natural gas service and transportation to residential, commercial, and industrial customers; generates, transmits, and distributes electricity; and provides wholesale and transmission transaction services. It serves approximately 3.4 million natural gas customers and 463,000 electric customers in in Ohio, Pennsylvania, Virginia, Kentucky, Maryland, Indiana, and Massachusetts. The company also owns and operates 3 coal-fired electric generating stations with a net capability of 2,540 megawatts (MW), 3 gas-fired generating units with a net capability of 196 MW, and 2 hydroelectric generating plants with a net capability of 10 MW, as well as a combined cycle gas turbine plant with a capacity of 5 35 MW. The company was formerly known as NIPSCO Industries, Inc. and changed its name to NiSource Inc. in April 1999. NiSource Inc. was founded in 1912 and is headquartered in Merrillville, Indiana.
- [By Lisa Levin]
In trading on Thursday, utilities shares fell by 2.01 percent. Meanwhile, top losers in the sector included Unitil Corporation (NYSE: UTL), down 9 percent, and NiSource Inc. (NYSE: NI), down 5 percent.
Top Performing Stocks For 2016: Immunomedics, Inc.(IMMU)
Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases. The company is developing Yttrium-90-labeled clivatuzumab tetraxetan, which is in Phase III registration study used for the treatment of pancreatic cancer. It is also developing antibody-drug conjugate (ADC) products comprising IMMU-132, an ADC that contains SN-38, which is in Phase II trials used for the treatment of patients with metastatic triple-negative breast cancer, and small-cell and non-small-cell lung cancers; IMMU-130, an anti-CEACAM5-SN-38 ADC that is in Phase II trials for the treatment of metastatic colorectal cancer; and epratuzumab, which is in two Phase III clinical trials for the treatment of systemic lupus erythematosus. Its early-stage products include Veltuzumab, a humanized monoclonal antibody targeting CD20 r eceptors on B lymphocytes for the treatment of non-Hodgkin lymphoma (NHL) and autoimmune diseases; Milatuzumab, a humanized monoclonal antibody targeting tumors that expresses the CD74 antigen, which is in Phase 1 studies; Yttrium-90-Labeled Epratuzumab Tetraxetan, a radiolabeled anti-CD22 investigational product candidate for patients with NHL or acute lymphoblastic leukemia; and IMMU-114, a novel humanized antibody for the treatment of patients with B-cell cancers. The company also provides LeukoScan, a diagnostic imaging product for diagnostic imaging to determine the location and extent of infection/inflammation in bone. In addition, it offers other product candidates for the treatment of solid tumors and hematologic malignancies, as well as other diseases, which are in various stages of clinical and pre-clinical development. The company has a collaboration agreement with Algeta ASA for the development of epratuzumab. Immunomedics, Inc. was founded in 1982 and is headqua rtered in Morris Plains, New Jersey.
- [By Monica Gerson]
Immunomedics, Inc. (NASDAQ: IMMU) fell 3.38 percent to $4.00 in pre-market trading after dropping 0.72 percent on Friday.
ViaSat, Inc. (NASDAQ: VSAT) shares fell 1.53 percent to $72.87. Drexel Hamilton downgraded Viasat from Hold to Sell.
- [By Lisa Levin]
Immunomedics, Inc. (NASDAQ: IMMU) shares dropped 18 percent to $4.32 as the company issued an update on triple-negative breast cancer presentation at the the American Society of Clinical Oncology. Immunomedics said that triple-negative breast cancer presentation was cancelled following a complaint that the company violated the embargo.
5 Best Industrial Disributor Stocks To Watch For 2016: NRG Energy Inc.(NRG)
NRG Energy, Inc., together with its subsidiaries, operates as a wholesale power generation company. The company engages in the ownership, development, construction, and operation of power generation facilities. It also involves in the transacting in and trading of fuel and transportation services; the trading of energy, capacity, and related products in the United States and internationally; and the supply of electricity, energy services, and cleaner energy and carbon offset products to retail electricity customers in deregulated markets. The company operates natural gas- fired, coal- fired, oil-fired, nuclear, solar, and wind power plants. As of December 31, 2010, it had power generation portfolio of 193 operating fossil fuel and nuclear generation units with an aggregate generation capacity of approximately 24,570 megawatt (MW), as well as ownership interests in renewable facilities with an aggregate generation capacity of 470 MW. The company portfolio also includes appr oximately 24,035 MW generation capacity in the United States, and 1,005 MW generation capacity in Australia and Germany. In addition, it has a district energy business with steam and chilled water capacity of approximately 1,140 megawatts thermal equivalent. NRG Energy, Inc. was founded in 1989 and is headquartered in Princeton, New Jersey.
- [By Lisa Levin]
In trading on Friday, utilities shares rose by just 0.1 percent. Meanwhile, top losers in the sector included NRG Energy Inc (NYSE: NRG), down 4 percent, and Calpine Corporation (NYSE: CPN), down 7 percent.
- [By Stoyan Bojinov]
Deutsche Bank announced on Monday that is was maintaining a “Hold” rating on the New Jersey-based electric utility company NRG Energy Inc. (NRG), but went on to lower its price target for the company.
Greg Poole, an analyst with the firm, commented, “NRG has several diverse businesses – generation, retail, solar, clean energy technologies, and now a separate MLP-like income vehicle for contracted assets. This helps to diversify away from the seemingly perennially challenged merchant generation business, but it also results in an increasingly complex story that may pose a challenge for investors and valuation.” As such, Deutsche Bank announced it was lowering its price target from $27 to $26 a share.
NRG Energy Inc. shares crept higher, gaining 1.11% on the day. The stock is up almost 15% YTD.
5 Best Industrial Disributor Stocks To Watch For 2016: Navidea Biopharmaceuticals, Inc.(NAVB)
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The company offers Lymphoseek, a receptor-targeted small-molecule radiopharmaceutical used in the evaluation of lymphatic basins that may have cancer involvement in patients; and Manocept platform to target the CD206 mannose receptor expressed on activated macrophages. Its neurological development programs include NAV4694, an Fluorine-18 labeled positron emission tomography imaging agent, which is used as an aid the imaging and evaluation of patients with signs or symptoms of Alzheimers disease and mild cognitive impairment; and NAV5001, an Iodine-123 labeled single photon emission computed tomography imaging agent that is used as an aid in the diagnosis of Parkinsons disease and other movement disorders with potential use as a diagnostic aid in dementi a. Navidea Biopharmaceuticals, Inc. has research and development agreements with University of California. The company was formerly known as Neoprobe Corporation and changed its name to Navidea Biopharmaceuticals, Inc. in January 2012. Navidea Biopharmaceuticals, Inc. was founded in 1983 and is headquartered in Dublin, Ohio.
- [By Monica Gerson]
Navidea Biopharmaceuticals Inc (NYSE: NAVB) shares rose 8.80 percent to $0.950 in pre-market trading as the company reported an unsolicited offer to refinance CRG loan.